UPDATE 1-FDA staff concerned about safety of Endo's testosterone injection
April 16, 2013 at 09:44 AM EDT
April 16 (Reuters) - Reviewers for the U.S. Food and Drug Administration said safety data on Endo Health Solutions Inc's twice-rejected testosterone injection Aveed was "concerning" and showed that the therapy was associated with severe and immediate post-injection adverse events.